tm
Seeing Is Believing
tm
Seeing Is Believing
Indaptus Therapeutics's activity chart (see below) currently has 13 price targets and 21 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 311 days.
Most recent stock forecast was given by from MAXIM GROUP on 13-Nov-2024. First documented stock forecast 25-Feb-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Apr-2023
$5
$1.59 (46.63%)
$8
1 years 11 months 7 days ago
(13-Nov-2024)
2/3 (66.67%)
$-27.9 (-84.80%)
444
Buy Since 31-Jan-2022
$12
$8.59 (251.91%)
2 years 4 days ago
(16-Oct-2024)
2/2 (100%)
$-28.04 (-70.03%)
680
Hold Since 08-Dec-2020
$1456
$1453.37 (55261.22%)
$29119.99
5 years 10 months 11 days ago
(08-Dec-2020)
0/2 (0%)
$936.32 (180.17%)
Buy Since 05-Oct-2018
$100
$96.15 (2497.40%)
$850
7 years 9 days ago
(11-Oct-2019)
2/2 (100%)
$-1538.34 (-93.90%)
684
Buy Since 09-May-2019
$1700
7 years 2 months 28 days ago
(22-Jul-2019)
1/2 (50%)
$-11090.4 (-86.71%)
74
What is INDP (Indaptus Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on INDP (Indaptus Therapeutics)?
Which analyst has the current lower performing score on INDP (Indaptus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on INDP (Indaptus Therapeutics)?
Which analyst is the currently most bullish on INDP (Indaptus Therapeutics)?
Which analyst is the currently most reserved on INDP (Indaptus Therapeutics)?
